|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:appearance
|
white crystalline solid
|
|
gptkbp:ATCCode
|
N02BA05
|
|
gptkbp:boilingPoint
|
Not applicable (decomposes)
|
|
gptkbp:CASNumber
|
65-45-2
|
|
gptkbp:category
|
gptkb:antipyretic
non-opioid analgesic
salicylamide derivative
|
|
gptkbp:chemicalFormula
|
C7H7NO2
|
|
gptkbp:hasInChIKey
|
InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)
QHUFMAHRWVTWDM-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
C1=CC=C(C(=C1)C(=O)N)O
|
|
gptkbp:IUPACName
|
2-hydroxybenzamide
|
|
gptkbp:KEGGID
|
C07398
|
|
gptkbp:meltingPoint
|
140–144 °C
|
|
gptkbp:molecularWeight
|
137.14 g/mol
|
|
gptkbp:PubChem_CID
|
4965
5147
CHEBI:32168
|
|
gptkbp:relatedTo
|
gptkb:paracetamol
gptkb:salicylic_acid
|
|
gptkbp:riskFactor
|
may cause skin and eye irritation
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:solubility
|
slightly soluble
|
|
gptkbp:structure
|
contains amide group
contains benzene ring
contains hydroxyl group
|
|
gptkbp:UNII
|
O414PZ4LPZ
|
|
gptkbp:uses
|
gptkb:analgesic
gptkb:antipyretic
component in over-the-counter medications
|
|
gptkbp:bfsParent
|
gptkb:salicylic_acid
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
salicylamide
|